Clinical trial · Observational
Selective Axillary Dissection After Neoadjuvant Chemotherap Yin Patients With Lymphnode-positive Breast Cancer
Selective Axillary Dissection After Neoadjuvant Chemotherapy in Patients With Lymphnode-positive Breast Cancer
NCT07828925CI-TRIAL-00126450CLYPcompletedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 19, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260919-000001
Summary
Brief summary (as posted)
The aim of this observational study is to collect data regarding the selective axillary dissection tecnique of lymphnode restaging after neoadjuvant chemotherapy in patients with Breast Cancer that is lymphonode positive at the time of the diagnosis.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Cancer Female | Breast Neoplasm | ONTOLOGY_EXACT | 0.90 |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- Number of patients where the lymph node containing the clip does not match the sentinel lymph node
- timeFrame
- From enrolment until Surgery Time
- description
- To verify the number Number of patients where the lymph node containing the clip does not match the sentinel
Secondary outcomes (2)
- measure
- Number of Patients that will not undergo to Selective Axillary Dissection
- timeFrame
- From enrolment until Surgery Time
- description
- To assess Number of Patients that will not undergo to Selective Axillary Dissection
- measure
- Number of preoperative correct identification of the lymph node with the clip
- timeFrame
- From enrolment until Surgery Time
- description
- To assess the match between preoperative identification of the lymph node and the lymph node with clip at surgery time
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Age\>= 18 years * Female sex * Diagnosis of Lymph Node- Positive (cN+) Breast Cancer through core needle biopsy, cT1-3 (multifocal too) * Absence of distant metastases (M0) * Patients that will undergo to NACT Exclusion Criteria: * Previous diagnosis of Breast Cancer * Previous Breast and/or Axillary Surgery * Pregnancy * Inflammatory Breast Cancer (cT4) * Patients that will not undergo to NACT
References
Publications (0)
Data not yet available
No reference posted for this study.